healthy lifestyle
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
BioRay Pharmaceutical Co., Ltd
healthy lifestyle
BioRay Pharmaceutical Co., Ltd